Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

249 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A case control study of syngeneic transplantation versus autologous transplantation for multiple myeloma: two decades of experiences from a single center.
Mohyuddin GR, Faisal MS, Badar T, Shah N, Bashir Q, Patel KK, Hosing C, Popat UR, Rondon G, Delgado R, Shah JJ, Weber DM, Thomas SK, Manasanch EE, Orlowski RZ, Champlin RE, Qazilbash MH. Mohyuddin GR, et al. Among authors: weber dm. Leuk Lymphoma. 2018 Feb;59(2):515-518. doi: 10.1080/10428194.2017.1344906. Epub 2017 Jul 3. Leuk Lymphoma. 2018. PMID: 28673185 No abstract available.
Intensive sequential therapy for VAD-resistant multiple myeloma.
Dimopoulos MA, Weber DM, Hester J, Delasalle K, Champlin R, Alexanian R. Dimopoulos MA, et al. Among authors: weber dm. Leuk Lymphoma. 1994 May;13(5-6):479-84. doi: 10.3109/10428199409049638. Leuk Lymphoma. 1994. PMID: 7915163 Clinical Trial.
Newly diagnosed multiple myeloma.
Weber DM. Weber DM. Curr Treat Options Oncol. 2002 Jun;3(3):235-45. doi: 10.1007/s11864-002-0013-4. Curr Treat Options Oncol. 2002. PMID: 12057069 Review.
166Ho-DOTMP plus melphalan followed by peripheral blood stem cell transplantation in patients with multiple myeloma: results of two phase 1/2 trials.
Giralt S, Bensinger W, Goodman M, Podoloff D, Eary J, Wendt R, Alexanian R, Weber D, Maloney D, Holmberg L, Rajandran J, Breitz H, Ghalie R, Champlin R. Giralt S, et al. Blood. 2003 Oct 1;102(7):2684-91. doi: 10.1182/blood-2002-10-3250. Epub 2003 May 1. Blood. 2003. PMID: 12730103 Free article. Clinical Trial.
Autologous stem cell transplantation is safe and feasible in elderly patients with multiple myeloma.
Qazilbash MH, Saliba RM, Hosing C, Mendoza F, Qureshi SR, Weber DM, Wang M, Flosser T, Couriel DR, De Lima M, Kebriaei P, Popat U, Alousi AM, Champlin RE, Giralt SA. Qazilbash MH, et al. Among authors: weber dm. Bone Marrow Transplant. 2007 Mar;39(5):279-83. doi: 10.1038/sj.bmt.1705580. Epub 2007 Jan 29. Bone Marrow Transplant. 2007. PMID: 17262062 Clinical Trial.
Results of a retrospective single institution analysis of targeted skeletal radiotherapy with (166)Holmium-DOTMP as conditioning regimen for autologous stem cell transplant for patients with multiple myeloma. Impact on transplant outcomes.
Christoforidou AV, Saliba RM, Williams P, Qazilbash M, Roden L, Aleman A, Weber D, Mendoza F, Podoloff D, Wendt R 3rd, Breitz H, Alexanian R, Champlin R, Giralt S. Christoforidou AV, et al. Biol Blood Marrow Transplant. 2007 May;13(5):543-9. doi: 10.1016/j.bbmt.2006.12.448. Epub 2007 Feb 26. Biol Blood Marrow Transplant. 2007. PMID: 17448913 Free article.
249 results